MarketInOut Stock Screener Log In | Sign Up

Syngene International Ltd

BSE • Healthcare • Diagnostics & Research • Quote as of 10/27/2026 15:51
Syngene International Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeBSE
Market Capitalization147,462 mln
Float191 mln
Earnings Date10/27/2026

EPS

5.49
Stretched

P / E

67.49
Richly valued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.66
Likely reliable

Relative Strength

72 / 100
Outperforming

Debt / Equity

0.10
Very low leverage

Business Description

Syngene International Limited is an India-based company that helps pharmaceutical, biotechnology, and other life sciences businesses research, develop, and manufacture new drugs and related products. Working with clients across the United States, Europe, and other global markets, Syngene supports the full journey from early drug discovery through to clinical trials and regulatory submissions. The company handles a wide range of work, including chemistry, biology, safety testing, and data analysis, covering both traditional small-molecule drugs and more complex treatments such as peptides and antibody-drug conjugates. Founded in 1993 and headquartered in Bengaluru, Syngene operates as a subsidiary of Biocon Limited and counts major industry names such as Bristol-Myers Squibb, Baxter, and Amgen among its partners.

Key Fundamentals

EPS5.49
P/E67.49
ROE4.59
RPS89.07
ROIC6.20
ROA3.29
Interest Cover9.73
EBITDA, mln7,911
EV / EBITDA17.79
EV / EBIT41.74
Revenue, mln36,002
EV / Revenue3.91

Quote Details

Last 370.50
Change 11 (3.06%)
Open 360.00
Volume 33,165
Turnover 12,287,632
Average Volume 77,853

Financial Ratios

Pre-Tax Profit Margin8
Leverage Ratio1.39
Current Ratio1.56
Price / Book3.02
Price / Tangible Book3.05
Price / Free Cash Flow24.03
Debt / Equity0.10
Price / Sales4.07
PEG Ratio9.23

Financial Strength

Altman Z-Score5.56
Piotroski F-Score 4 / 9
Beneish M-Score-2.66
Price to Intrinsic Value1.69
Price to Graham Number2.64
Shiller PE Ratio30.70

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.83% 27 / 100   
1 Month -2.58% 70 / 100   
2 Months -10.94% 41 / 100   
6 Months -11.67% 42 / 100   
1 Year -41.74% 17 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog